First Wilshire Securities Management Inc Evofem Biosciences, Inc. Transaction History

First Wilshire Securities Management Inc

  • $327 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.29 - $4.46 $21,266 - $327,065
73,333 New
73,333 $83,000

About Evofem Biosciences, Inc.

EVFM Quotes by TradingView
  • Ticker EVFM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,459,200
  • Market Cap $855K
  • Description
  • Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prev...
More about EVFM
Track This Portfolio

Track First Wilshire Securities Management Inc Portfolio

Follow First Wilshire Securities Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Wilshire Securities Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on First Wilshire Securities Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email